Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala

Neuroscience

Volumn 129, Issue 3, 2004, Pages 509-519

  Amat, J ^a   Tamblyn, J P ^a   Paul, E D ^a   Bland, S T ^a   Amat, P ^a   Foster, A C ^b   Watkins, L R ^a   Maier, S F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

anxiety; behavioral depression; learned helplessness; stress; urocortin

Indexed keywords

ANTISAUVAGINE 30; ASV 30; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR AGONIST; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; HORMONE RECEPTOR STIMULATING AGENT; PROTEIN C FOS; SEROTONIN; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CELL LABELING; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; EXTRACELLULAR SPACE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SEROTONINERGIC NERVE CELL;

AMYGDALA; ANIMALS; CELL COUNT; CORTICOTROPIN-RELEASING HORMONE; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; MICROINJECTIONS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-FOS; RAPHE NUCLEI; RATS; SEROTONIN; TIME FACTORS;

EID: 8444250238     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.07.052     Document Type: Article

References (71)

1. J. Amat, P.D. Sparks, P. Matus-Amat, J. Griggs, L.R. Watkins, S.F. Maier The role of the habenular complex in the elevation of dorsal raphe nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress Brain Res 917 2001 118 126
2. J. Amat, P. Matus-Amat, L.R. Watkins, S.F. Maier Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat Brain Res 812 1998 113 120
3. J. Amat, P. Matus-Amat, L.R. Watkins, S.F. Maier Escapable and inescapable stress differentially and selectively alter extracellular levels of 5-HT in the ventral hippocampus and dorsal periaqueductal gray of the rat Brain Res 797 1998 12 22
4. 1 receptors in amygdala J Neurosci 22 2002 2926 2935
5. T.L. Bale, A. Contarino, G.W. Smith, R. Chan, L.H. Gold, P.E. Sawchenko, G.F. Koob, W.W. Vale, K.F. Lee Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour are hyper-sensitive to stress Nat Genet 24 2000 410 414
6. S.T. Bland, D. Hargrave, J.L. Pepin, J. Amat, L.R. Watkins, S.F. Maier Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex Neuropsychopharmacology 28 2003 1589 1596
7. S.T. Bland, C. Twining, L.R. Watkins, S.F. Maier Stressor controllability modulates stress-induced serotonin but not dopamine efflux in the nucleus accumbens shell Synapse 49 2003 206 208
8. B.M. Campbell, K.M. Merchant Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment Brain Res 993 2003 1 9
9. 2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression J Neurosci 15 1995 6340 6350
10. F. Chaouloff Serotonin, stress and corticoids J Psychopharmacol 14 2000 139 151
11. C. Chen, R. Dagnino, E.B. De Souza, D.E. Grigoriadis, C.Q. Huang, K.-I. Kim, Z. Liu, T. Moran, T.R. Webb, J.P. Witten, Y.F. Xie, J.R. McCarthy Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor-1 receptor antagonists J Med Chem 39 1996 4358 4360
12. K.G. Commons, K.R. Connolley, R.J. Valentino A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders Neuropsychopharmacology 28 2003 206 215
13. S.C. Coste, R.A. Kesterson, K.A. Heldwein, S.L. Stevens, A.D. Heard, J.H. Hollis, S.E. Murray, J.K. Hill, G.A. Pantely, A.R. Hohimer, D.C. Hatton, T.J. Phillips, D.A. Finn, M.J. Low, M.B. Rittenberg, P. Stenzel, M.P. Stenzel Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 Nat Genet 24 2000 403 409
14. H.E. Day, B.N. Greenwood, S.E. Hammack, L.R. Watkins, M. Fleshner, S.F. Maier, S. Campeau Differential expression of 5-HT-1A, alpha1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catechol-aminergic cells of the rat dorsal raphe nucleus J Comp Neurol 474 2004 364 378
15. S. Feldman, J. Weidenfeld The excitatory effects of the amygdala on hypothalmo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41 Brain Res Bull 45 1998 389 393
16. R.E. Grahn, M.J. Will, S.E. Hammack, S. Maswood, M.B. McQueen, L.R. Watkins, S.F. Maier Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor Brain Res 826 1999 35 43
17. F.G. Graeff, M.B. Viana, P.O. Mora Dual role of 5-HT in defense and anxiety Neurosci Biobehav Rev 21 1997 791 799
18. 125I]-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 receptors Mol Pharmacol 50 1996 679 686
19. S.E. Hammack, K.J. Richey, M.J. Schmid, M.L. LoPresti, L.R. Watkins, S.F. Maier The role of corticotropin releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress J Neurosci 22 2002 1020 1026
20. S.E. Hammack, J.L. Pepin, J.S. DesMarteau, L.R. Watkins, S.F. Maier Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress Behav Brain Res 147 2003 55 64
21. Hammack SE, Richey KJ, Watkins LR, Maier SF (2004) Chemical lesion of the bed nucleus of the stria terminalis blocks behavioral consequences of uncontrollable stress. Behav Neurosci 118:443-448.
22. S.E. Hammack, M.J. Schmid, M.L. LoPresti, A. Der-Avakian, M.A. Pelleymounter, A.C. Foster, L.R. Watkins, S.F. Maier Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress J Neurosci 23 2003 1019 1025
23. 1, but not CRF, receptors mediate anxiogenic-like behavior Regul Pept 71 1997 15 21
24. 125I- antisauvagine-30: a novel and specific high affinity radioligand for the characterization of corticotropin releasing factor type 2 receptors Neuropsychopharmacology 40 2001 114 122
25. S.P. Ho, L.K. Takahashi, V. Livanov, K. Spencer, T. Lesher, C. Maciag, M.A. Smith, K.W. Rohrbach, P.R. Hartig, S.P. Arneric Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor Mol Brain Res 89 2001 29 40
26. H. Imai, D.A. Steindler, S.T. Kitai The organization of divergent axonal projections from the midbrain raphe nuclei in the rat J Comp Neurol 243 1986 363 380
27. K. Inoue, G.R. Valdez, T.M. Reyes, L.E. Reinhardt, A. Tabarin, J. Rivier, W. Vale, P.E. Sawchenko, G.F. Koob, E.P. Zorrilla Human urocortin 2, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreasing feeding and drinking in the rat J Pharmacol Exp Ther 305 2003 385 393
28. N.H. Kalin, J.E. Sherman, L.K. Takahashi Antagonism of endogenous CRF systems attenuates stress-induced freezing behavior in rats Brain Res 457 1988 130 135
29. H. Kawahara, M. Yopshida, H. Yokoo, M. Nishi, M. Tanaka Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis Neurosci Lett 162 1993 81 84
30. L.G. Kirby, J.M. Chou-Green, K. David, I. Lucki The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid Brain Res 760 1997 218 230
31. L.G. Kirby, K.G. Rice, R.J. Valentino Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nuclcus Neuropsychopharmacology 22 2000 148 162
32. 2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 Nat Genet 24 2000 415 419
33. G.F. Koob, S.C. Heinrichs A role for corticotropin releasing factor and urocortin in behavioral responses to stressors Brain Res 848 1999 141 152
34. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT (1993) The role of corticotropin-releasing factor in behavioural responses to stress. In: Corticotropin releasing factor, CIBA Foundation symposium, Vol. 172, pp 277-295. London: Wiley.
35. W.A. Kostich, A. Chen, K. Sperle, B.L. Largent Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRFgamma receptor Mol Endocrinol 12 1998 1077 1085
36. K. Lewis, C. Li, M.H. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T.M. Reyes, J. Gulyas, W. Fischer, L. Bilezikjian, J. Rivier, P.E. Sawchenko, W.W. Vale Identification of urocortin 2I, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF-2 receptor Proc Natl Acad Sci USA 98 2001 7570 7575
37. J. Liu, B. Yu, V. Neugebauer, D.E. Grigoriadis, J. Rivier, W.W. Vale, P. Shinnick-Gallagher, J.P. Gallagher Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission J Neurosci 24 2004 420 429
38. C.A. Lowry Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis J Neuroendocrinol 14 2002 911 923
39. C.A. Lowry, J.E. Rodda, S.L. Lightman, C.D. Ingram Corticotropin- releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system J Neurosci 20 2000 7728 7736
40. S.F. Maier, R.E. Grahn, B.A. Kalman, L.C. Sutton, E.P. Wiertelak, L.R. Watkins The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock Behav Neurosci 107 1993 377 388
41. S.F. Maier, R.E. Grahn, L.R. Watkins 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and the interference with escape produced by exposure to inescapable shock Behav Neurosci 109 1995 404 412
42. S.F. Maier, B.A. Kalman, R.E. Grahn Chlordiazepoxide microinjected in the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing Behav Neurosci 108 1994 121 130
43. S.F. Maier, M.E.P. Seligman Learned helplessness: theory and evidence J Exp Psychol Gen 105 1976 3 46
44. S.F. Maier, L.R. Watkins Stressor controllability, anxiety, and serotonin Cogn Ther Res 22 1998 595 613
45. R.S. Mansbach, E.N. Brooks, Y.L. Chen Antidepressant-like effects of CP- 154,526, a selective CRF1 receptor antagonist Eur J Pharmacol 323 1997 21 26
46. S. Maswood, J.E. Barter, L.R. Watkins, S.F. Maier Exposure to inescapable but not to escapable shock increases extracellular levels of 5-HT in the dorsal raphe nucleus of the rat Brain Res 783 1998 115 120
47. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. 4th edition. Academic Press.
48. L. Pernar, A.L. Curtis, W.W. Vale, J.E. Rivier, R.J. Valentino Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions J Neurosci 24 2004 1305 1311
49. M.A. Pelleymounter, M. Joppa, N. Ling, A.C. Foster Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress J Pharmacol Exp Ther 302 2002 145 152
50. 2 receptor agonists urocortin II and urocortin III Peptides 25 2004 659 666
51. M.L. Price, A.L. Curtis, L.G. Kirby, R.J. Valentino, I. Lucki Effects of corticotropin-releasing factor on brain serotonergic activity Neuropsychopharmacology 18 1998 492 502
52. M.L. Price, I. Lucki Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor J Neurosci 21 2001 2833 2841
53. J. Radulovic, A. Ruhmann, T. Liepold, J. Spiess Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2 J Neurosci 19 1999 5016 5025
54. T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, P.E. Sawchenko Urocortin 2: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors Proc Natl Acad Sci USA 98 2001 2843 2848
55. V.B. Risbrough, R.L. Hauger, M.A. Pelleymounter, M.A. Geyer Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice Psychopharmacology 170 2003 178 187
56. A. Romaniuk, M. Koprowska, M. Krotewicz, M. Strzelczuk, M. Wieczorek Effects of 8-OHDPAT administration into the dorsal raphe nucleus and dorsal hippocampus on fear behavior and regional brain monoamines distribution in rats Behav Brain Res 120 2001 47 57
57. M. Sakanaka, T. Shibasaki, K. Lederis Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method J Comp Neurol 260 1987 256 298
58. D.J. Stein, S. Stahl Serotonin and anxiety: current models Int Clin Psychopharmacol 15 suppl 2 2000 S1 S6
59. L.W. Swanson, P.E. Sawchenko, J. River, W.W. Vale Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study Neuroendocrinology 36 1983 165 186
60. 1 and CRF receptors in fear and anxiety Neurosci Biobehav Rev 25 2001 627 636
61. L.K. Takahashi, S.W. Ho, V. Livanov, N. Graciani, S.P. Arneric Antagonism of CRF receptors produces anxiolytic behavior in animal models of anxiety Brain Res 902 2001 135 142
62. K. Takamori, N. Kawashima, S. Chaki, A. Nakazato, K. Kameo Involvement of corticotropin-releasing factor subtype 1 receptor in the acquisition phase of learned helplessness in rats Life Sci 69 2001 1241 1248
63. G.R. Valdez, K. Inoue, G.F. Koob, J. Rivier, W. Vale, E.P. Zorrilla Human urocortin 2: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide Brain Res 943 2002 142 150
64. G.R. Valdez, E.P. Zorrilla, J. Rivier, W. Vale, G.F. Koob Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist Brain Res 980 2003 206 212
65. W. Vale, J. Spiess, C. Rivier, J. Rivier Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 213 1981 1394 1397
66. R.J. Valentino, L. Liouterman, E.J. van Bockstaele Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus J Comp Neurol 435 2001 450 463
67. K. Van Pett, V. Viau, J.C. Bittencourt, R.K.W. Chan, H.Y. Li, C. Arias, G.S. Prins, M. Perrin, W. Vale, P.E. Sawchenko Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse J Comp Neurol 428 2000 191 212
68. M. Venihaki, S. Sakihara, S. Subramanian, P. Dikkes, S.C. Weninger, G. Liapakis, T. Graf, J.A. Majzoub Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours J Neuroendocrinol 16 2004 411 422
69. R.P. Vertes A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat J Comp Neurol 313 1991 643 668
70. R.P. Vertes, W.J. Fortin, A.M. Crane Projections of the median raphe nucleus in the rat J Comp Neurol 407 1999 555 582
71. J.M. Weiss, P.A. Goodman, B.G. Losito, S. Corrigan, J.M. Charry, W.H. Bailey Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain Brain Res Rev 3 1981 167 205